Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Dermatologic 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 10Melanoma 9Lung Neoplasms 5Colorectal Neoplasms 5Triple Negative Breast Neoplasms 3Rectal Neoplasms 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Colonic Neoplasms 3Thyroid Neoplasms 1Thyroid Diseases 1Spinocerebellar Degenerations 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Neoplasms 1Non-small Cell Carcinoma 1Neurofibromatosis 1 1Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Leukemia 1Hereditary Sensory and Autonomic Neuropathies 1Glioma 1Gastrointestinal Stromal Tumors 1Fallopian Tube Neoplasms 1Disease Progression 1Central Nervous System Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma 1Brain Neoplasms 1Brain Diseases 1Blast Crisis 1

Interventions

Temozolomide 30Radiotherapy 23Filgrastim 12Carmustine 12Irinotecan 11Carboplatin 11Chemotherapy, Adjuvant 9O(6)-benzylguanine 8Etoposide 7Surgical Procedures, Operative 6Magnetic Resonance Spectroscopy 6Vincristine 5Peripheral Blood Stem Cell Transplantation 5Granulocyte Colony-Stimulating Factor 5Cyclophosphamide 5sargramostim 4motexafin gadolinium 4Topotecan 4Thiotepa 4Paclitaxel 4Melphalan 4Gene Expression Profiling 4Gemcitabine 4Drug Therapy 4Busulfan 4temsirolimus 3etoposide phosphate 3Specimen Handling 3Mass Spectrometry 3Imatinib Mesylate 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Central Nervous System Neoplasms × binimetinib × Clear all
NCT04543188 2025-10-23

A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement

Pfizer

Phase 1 Terminated
65 enrolled 52 charts
CNSDermatologicThoracic

Brain Diseases, Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡